Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS

被引：0

作者：

Raghavan, Manoj ^{[3
]}

Jenkins, Stephen ^{[1
,2
]}

Wintrich, Sophie ^{[4
]}

Drayson, Mark ^{[3
]}

Bunce, Chris ^{[3
]}

Culligan, Dominic ^{[5
]}

Kulasekararaj, Austin ^{[6
,7
]}

Wiseman, Dan ^{[8
,9
]}

Foster, Bethany ^{[1
]}

Dunn, Janet ^{[1
]}

机构：

[1] Univ Warwick, Coventry, W Midlands, England

[2] Dudley Grp NHS Fdn Trust, Dudley, England

[3] Univ Birmingham, Birmingham, W Midlands, England

[4] MDS UK Support Grp, Aberdeen, Scotland

[5] Aberdeen Royal Infirm, Aberdeen, Scotland

[6] Kings Coll Hosp London, London, England

[7] Kings Coll London, London, England

[8] CRCUK Manchester, Machester, England

[9] Christie NHS Fdn Trust, Machester, England

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH23-EP17

引用

页码：153 / 153

页数：1